BioAtla, Inc.BCABNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank96
3Y CAGR+38.1%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+38.1%/yr
Quarterly compound
Percentile
P96
Near historical high
vs 3Y Ago
2.6x
Strong expansion
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 26.05% |
| Q2 2025 | -5.86% |
| Q1 2025 | -8.43% |
| Q4 2024 | -44.13% |
| Q3 2024 | 48.71% |
| Q2 2024 | 10.16% |
| Q1 2024 | 14.29% |
| Q4 2023 | 18.52% |
| Q3 2023 | 5.86% |
| Q2 2023 | -28.59% |
| Q1 2023 | -1.30% |
| Q4 2022 | -9.10% |
| Q3 2022 | 9.90% |
| Q2 2022 | -19.34% |
| Q1 2022 | -3.65% |
| Q4 2021 | 0.87% |
| Q3 2021 | 22.21% |
| Q2 2021 | -62.05% |
| Q1 2021 | -14.23% |
| Q4 2020 | -105.30% |
| Q3 2020 | -77.32% |
| Q2 2020 | -307.57% |
| Q1 2020 | -40.03% |
| Q4 2019 | 0.00% |